Evidence map›Paper›PMID 35081855›Full record

ArticleBioengineered2022

MicroRNA-656-3p inhibits colorectal cancer cell migration, invasion, and chemo-resistance by targeting sphingosine-1-phosphate phosphatase 1.

Baoming Zhang, Shanting Gao, Zengtao Bao, Cheng Pan, Qingshui Tian, Qiang Tang

Open access · goldAbstract readVideo-Audio Media
In one paragraph

Article in Bioengineered, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Baoming ZhangGastrointestinal Department, The First People's Hospital of Lianyungang, Lianyungang City, Jiangsu Province, China.
Shanting GaoGastrointestinal Department, The First People's Hospital of Lianyungang, Lianyungang City, Jiangsu Province, China.
Zengtao BaoGastrointestinal Department, The First People's Hospital of Lianyungang, Lianyungang City, Jiangsu Province, China.
Cheng PanGastrointestinal Department, The First People's Hospital of Lianyungang, Lianyungang City, Jiangsu Province, China.
Qingshui TianGastrointestinal Department, The First People's Hospital of Lianyungang, Lianyungang City, Jiangsu Province, China.
Qiang TangGastrointestinal Department, The First People's Hospital of Lianyungang, Lianyungang City, Jiangsu Province, China.
The First People’s Hospital of Lianyungang · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer presents high rates of recurrence and metastasis, and the occurrence and progression and mechanism of its invasion and metastasis are not fully understood. The expression of miR-656-3p in patient samples and 10 cell lines were measured. Bioinformatic databases were used to predict miRNAs. Protein expressions were examined using Western blot. Transwell assay was used to measure cell migration and invasion. Transplanted tumor model in nude mice was established. Removal of the miR-656-3p by specific knocking-down of this gene promoted the chemo-resistance of colorectal cancer cells. Critically, we identified sphingosine-1-phosphate phosphatase 1 (SGPP1) as a downsteam target of the miR-656-3p, which we first obtained from 199 potential target genes from Targetscan, 200 genes from miRDB and 200 genes from DIANA, respectively. Then, we identified the interaction between SGPP1 and the miR-656-3p on 3' UTR of SGPP1 gene. Knockdown of SGPP1 greatly suppressed the tumor growth in vivo and epithelial mesenchymal transition process. miR-656-3p could regulate cell proliferation and chemoresistance in the colorectal cancer that associate to downstream target with SGPP1. Along with its downstream molecule, we would like to predict that the SGPP1 associated miR-656-3p could be used to develop early for early diagnostics for CRC oncogenesis.

Indexed as

Cell MovementDrug Resistance, NeoplasmAgedColorectal NeoplasmsFemaleHCT116 CellsHT29 CellsHumansMaleMembrane ProteinsMicroRNAsMiddle AgedNeoplasm InvasivenessNeoplasm ProteinsPhosphoric Monoester HydrolasesRNA, NeoplasmMembrane ProteinsMicroRNAsMIRN656 microRNA, humanNeoplasm ProteinsPhosphoric Monoester HydrolasesRNA, NeoplasmSGPP1 protein, human3’ UTR of SGPP1Colorectal cancer (CRC)metastasismiR-656-3pSGPP1

Identifiers

PMID35081855
PMCPMC8973708
OpenAlexW4210558516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.